Active

Pharma4Future

Switched

BE0776403737

Rechtspersoon Private limited company 1 establishment

Heiveld 29, 1745 Opwijk Activiteiten van holdings

Active for

4 year, 10 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 447,474

▲ 72% vs 2024

Profit

Growing

€ 246,977

▲ 90% vs 2024

Debts

High

€ 4.5 million

▼ 5% vs 2024

Pharma4Future from Opwijk, company number BE0776403737, closed financial year 2025 with a result of € 246,977 after tax. For that financial year Pharma4Future recorded a gross margin of € 447,474 and equity of € 563,772. Compared with financial year 2024, the result moved from € 129,711 to € 246,977. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What happened at Pharma4Future?

What happened at Pharma4Future in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 246,977 (▲ 90% vs 2024). Source: NBB ↗
  • New establishment in Opwijk. KBO
  • Start of the company according to the CBE. KBO
  • THE WALL COMPANY became a director. NBB
  • Pharma Officinalis became a director. NBB
  • TOURNOV became a director. NBB

In short

From € 70,184 profit in 2022 to € 246,977 profit in 2025.

Paid € 184,758 in corporate taxes since 2022.

Best year ever: 2025, with € 246,977 profit.

A new publication or filing at Pharma4Future? We notify you, reason included.

Follow Pharma4Future

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind Pharma4Future are THE WALL COMPANY, Pharma Officinalis and TOURNOV. It owns 100% of Apotheek Londerzeel and 100% of Apotheek Breendonkfarma itself.

See the full network in the app

Directors

According to the 2025 annual accounts

THE WALL COMPANY

Associate · represented by Walraevens Katrien

Also active at: APOTHEEK WALRAEVENS

since 2021

Pharma Officinalis

Associate · represented by Lenaerts Sven

Also active at: APOTHEEK OPWIJK LENAERTS

since 2021

TOURNOV

Associate · represented by Tournov Mariana

Also active at: ZONIAPHARMA

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Heiveld 29 box 101

1745 Opwijk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0776.403.737
VAT number
BE 0776.403.737
Registered office
Heiveld 29 bus 101, 1745 Opwijk
Names & denominations
Pharma4Future
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
22 October 2021
Peppol
Active · Active since 14 Mar 2025
Activities · NACE

Activiteiten van holdings

Holdings

Frequently asked questions

What is the enterprise number of Pharma4Future?
The enterprise number of Pharma4Future is BE0776403737.
What is the address of Pharma4Future?
The registered office of Pharma4Future is located at Heiveld 29 box 101, 1745 Opwijk.
When was Pharma4Future founded?
Pharma4Future was founded on 22 October 2021.
What is the main activity of Pharma4Future?
The main activity of Pharma4Future is "Activiteiten van holdings" (NACE code 64210).
Does Pharma4Future have a website?
No website is currently known for Pharma4Future.
How much profit did Pharma4Future make in 2025?
Pharma4Future posted a profit after taxes of € 246,977 in financial year 2025.
What is the revenue of Pharma4Future?
As a small company, Pharma4Future is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 447,474.
Where can I find the annual accounts of Pharma4Future?
Pharma4Future files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Pharma4Future?
According to the 2025 annual accounts, the directors of Pharma4Future are: THE WALL COMPANY, Pharma Officinalis, TOURNOV.
Who owns Pharma4Future?
Behind Pharma4Future are THE WALL COMPANY, Pharma Officinalis and TOURNOV. It owns 100% of Apotheek Londerzeel and 100% of Apotheek Breendonkfarma itself.